Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

BRTX

BioRestorative Therapies (BRTX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BRTX
DataOraFonteTitoloSimboloCompagnia
28/02/202513:57Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
27/02/202515:45GlobeNewswire Inc.BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic PainNASDAQ:BRTXBioRestorative Therapies Inc
27/02/202502:15GlobeNewswire Inc.BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline UpdateNASDAQ:BRTXBioRestorative Therapies Inc
25/02/202514:00GlobeNewswire Inc.BioRestorative to Provide a Positive FDA Update on Clinical PipelineNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202514:30GlobeNewswire Inc.BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
19/02/202522:43Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
19/02/202522:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202514:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202513:00GlobeNewswire Inc.BRTX-100 Front and Center at ORS 2025NASDAQ:BRTXBioRestorative Therapies Inc
05/12/202412:45GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
13/11/202413:00GlobeNewswire Inc.BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical DataNASDAQ:BRTXBioRestorative Therapies Inc
12/11/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BRTXBioRestorative Therapies Inc
12/11/202422:05GlobeNewswire Inc.BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
06/11/202422:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202422:25Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202413:00GlobeNewswire Inc.BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumNASDAQ:BRTXBioRestorative Therapies Inc
05/11/202413:10GlobeNewswire Inc.BioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthNASDAQ:BRTXBioRestorative Therapies Inc
31/10/202412:00GlobeNewswire Inc.BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
10/10/202413:00GlobeNewswire Inc.BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor EventsNASDAQ:BRTXBioRestorative Therapies Inc
03/10/202422:15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
19/09/202412:55GlobeNewswire Inc.BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 DrugsNASDAQ:BRTXBioRestorative Therapies Inc
13/08/202422:05GlobeNewswire Inc.BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
08/08/202422:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BRTXBioRestorative Therapies Inc
06/08/202422:05GlobeNewswire Inc.BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024NASDAQ:BRTXBioRestorative Therapies Inc
23/07/202413:10GlobeNewswire Inc.BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational MedicineNASDAQ:BRTXBioRestorative Therapies Inc
27/06/202413:40GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
17/06/202413:05GlobeNewswire Inc.BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial ResultsNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202417:40AllPennyStocks.comShares of Biotech MicroCap Rip on Licensing TalksNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202413:00GlobeNewswire Inc.BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
04/06/202414:50GlobeNewswire Inc.BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BRTX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network